• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 249-263 of 645 results

2064 Exhibit: Kaken Exhibit 2064

Document IPR2017-00190, No. 2064-110 Exhibit - Kaken Exhibit 2064 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2028 Exhibit: Kaken Exhibit 2028

Document IPR2017-00190, No. 2028-75 Exhibit - Kaken Exhibit 2028 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1038 Exhibit: Spruit, D, J Invest Dermatol, 565 359 361 1971

Document IPR2017-00190, No. 1038-38 Exhibit - Spruit, D, J Invest Dermatol, 565 359 361 1971 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1006 Exhibit: Prosecution History of US Pat No 7,214,506

Document IPR2017-00190, No. 1006-6 Exhibit - Prosecution History of US Pat No 7,214,506 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1644 Exhibit: Top 200 Drugs for 2006 by Sales

Document IPR2017-00190, No. 1644-293 Exhibit - Top 200 Drugs for 2006 by Sales (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1588 Exhibit: Valeant Pharmaceuticals International, Inc, US Securities and Excha...

Document IPR2017-00190, No. 1588-237 Exhibit - Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 Q, for the Quarterly Period Ended June 30, 2017 (P.T.A.B...

cite Cite Document
Analyze

1520 Exhibit: Label for Terbinafine Hydrochloride Cream, 1%

Document IPR2017-00190, No. 1520-169 Exhibit - Label for Terbinafine Hydrochloride Cream, 1% (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2091 Exhibit: Kaken Exhibit 2091

Document IPR2017-00190, No. 2091-137 Exhibit - Kaken Exhibit 2091 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2053 Exhibit: Kaken Exhibit 2053

Document IPR2017-00190, No. 2053-100 Exhibit - Kaken Exhibit 2053 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2084 Exhibit: Kaken Exhibit 2084

Document IPR2017-00190, No. 2084-130 Exhibit - Kaken Exhibit 2084 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1035 Exhibit: Vanderdonckt, J, et al, Mykosen, 197251 256 1975

Document IPR2017-00190, No. 1035-35 Exhibit - Vanderdonckt, J, et al, Mykosen, 197251 256 1975 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1618 Exhibit: Valeant Pharmaceuticals International, Inc Third Quarter 2014 Finan...

Document IPR2017-00190, No. 1618-267 Exhibit - Valeant Pharmaceuticals International, Inc Third Quarter 2014 Financial Results Conference Call Presentation, dated October 20, 2014 (P.T.A.B. Nov. 1,...

cite Cite Document
Analyze

1585 Exhibit: Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q1 2017...

Document IPR2017-00190, No. 1585-234 Exhibit - Thomas Reuters StreetEvents, Edited Transcript, VRXTO ¿¿¿ Q1 2017 Valeant Pharmaceuticals International Inc Earnings Call (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1515 Exhibit: Label for Kerydin¿¿ tavaborole topical solution, 5%, Anacor Pharmace...

Document IPR2017-00190, No. 1515-164 Exhibit - Label for Kerydin¿¿ tavaborole topical solution, 5%, Anacor Pharmaceuticals, Inc (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2088 Exhibit: Kaken Exhibit 2088

Document IPR2017-00190, No. 2088-134 Exhibit - Kaken Exhibit 2088 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 17 18 19 20 21 ... >>